Protecting Homeland: US Biodefence Programme Post 9/11

The US biodefence programme continued to remain covert until the advent of ProjectBioShield in 2003, which was pursued overtly with government sanctions. Project BioShield became a law in July 2004. Under the Project, efforts have been made to develop and make available effective drugs and vaccines to protect civilian population against any biological and chemical weapon attacks. This is a ten-year programme that aims to acquire medical countermeasures for civilian use, for which the administration appropriated $6 billion for 10 years, to purchase countermeasures to achieve three primary objectives....